The course has been accredited with 3 CME credits by the UEMS EACCME.
This course provides a comprehensive overview of pretargeting, a powerful strategy for targeted imaging and therapy in nuclear medicine.
The course duration is 3 hours.
Target Audience
- Nuclear Medicine physicians
- Radiologists
- Radiopharmacists and radiochemists
- Medical physicists
- Research scientists working in nuclear medicine and drug development
- Graduate students in related fields (e.g., biochemistry, radiochemistry)
Learning Objectives
- Explain the basic principles of pretargeting
- Describe the key components of the pretargeting approach, including targeting vectors, pretargeting molecules, and radioisotopes.
- Discuss the advantages and limitations of pretargeting compared to conventional radioimmunoconjugates.
- Analyze the specific steps involved in pretargeting with the Tz-TCO system.
- Evaluate the potential of other pretargeting systems beyond Tz-TCO.
- Explain the application of pretargeted PET/SPECT imaging in oncology and neuroscience.
- Discuss the therapeutic applications of pretargeting and its potential benefits.
Faculty
Johanna Steen
Speaker
Dennis Svatunek
Speaker
Sarah Cheal
Speaker
Filipe Elvas
Speaker
Matthias Herth
Speaker
Brian Zeglis
Speaker
Registration Details
Event Overview
Free
